Cardiology Research Summaries

Beta-Blockers Provide No Added Benefit After MI in Patients With Preserved Ejection Fraction

Aficamten Improves Exercise Capacity in Symptomatic Obstructive HCM

EMPA-KIDNEY: Cardiorenal Benefits of Empagliflozin Persist Even After Discontinuation

Finerenone Reduces Heart Failure Events in Patients with Preserved or Mildly Reduced Ejection Fraction